Side-by-side IPO readiness, funding history, and valuation comparison. Data sourced by TechStackIPO.
Scores, valuations, and signals for eMed, Shein, and 370+ companies. 5-min read every Tuesday.
AI-managed healthcare platform specializing in GLP-1 weight health, decentralized clinical trials, and remote diagnostic testing.
| Industry | Health Tech |
| Stage | Late Stage Private |
| IPO Status | Pre-IPO |
| Valuation | $2B+ |
| Total Funding | $342M |
| Headquarters | United States |
Shein is the world's largest fast fashion company, valued at $66B with $5.2B raised. Track IPO readiness score, funding history, and public market timeline.
| Industry | E-Commerce |
| Stage | Pre-IPO |
| IPO Status | Pre-IPO |
| Valuation | $30-50B |
| Total Funding | $5.2B |
| Headquarters | Singapore |
Complete funding history, cap table, S-1 analysis, and investor breakdown for any company. Instant PDF download.
Or buy any single company report for $19
eMed is valued at $2B+. Shein is valued at $30-50B. Both figures are based on the most recent funding rounds tracked by TechStackIPO.
eMed is currently pre-IPO. Shein filed an S-1 in June 2024 and is actively in the IPO pipeline. Track both companies on TechStackIPO for S-1 filings, roadshow announcements, and IPO date updates.
eMed has raised $342M. Shein has raised $5.2B.
eMed operates in Health Tech, while Shein operates in E-Commerce.
eMed is a Health Tech company valued at $2B+ with $342M raised. Shein is a E-Commerce company valued at $30-50B with $5.2B raised. See TechStackIPO's full side-by-side comparison for IPO readiness scores, funding timelines, and investor access options.
Accredited investors can access pre-IPO shares in eMed and Shein through secondary market platforms, pre-IPO funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace section tracks available access options for both companies. Pre-IPO investments carry higher risk and limited liquidity.